Form4insider filings, from the source

SEC Form 4 · accession 0001127602-15-012337

ARIAD PHARMACEUTICALS INC · ARIA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Timothy P Clackson
Officer — President, R&D, CSO
Period of report
Mar 19, 2015
Accepted (ET)
Mar 23, 2015 · 5:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884731

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockMar 19, 2015M10,833$0.00A439,065D
Common StockMar 19, 2015M20,657$7.56A460,971D
Common StockMar 19, 2015S20,657$9.00D440,314D
Common StockF3Mar 20, 2015S5,417$8.8443D433,648D
Common StockMar 23, 2015M13,333$0.00A446,981D
Common StockF3Mar 23, 2015S6,667$8.552D440,314D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF6,F7—Mar 19, 2015M10,833D——Common Stock10,83310,833D
Employee Stock Option (Right to Buy)$7.56Mar 19, 2015M20,657DOct 4, 2006Oct 4, 2015Common Stock20,6570D
Restricted Stock UnitsF6,F8—Mar 23, 2015M13,333D——Common Stock13,3330D

Explanation of responses